Effect of cinobufacin on P53,PTEN and HIF-1αin patients with advanced lung cancer
- VernacularTitle:华蟾素对晚期肺癌患者血清P53、PTEN及HIF-1α影响研究
- Author:
Dahai ZHANG
;
Zhongfang CAI
;
Haifeng MA
- Publication Type:Journal Article
- Keywords:
advanced lung cancer;
cinobufacin;
P53;
PTEN;
HIF-1α
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(6):68-70
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of cinobufacin on P53,PTEN and HIF-1αin patients with advanced lung cancer.Methods 100 cases with advanced lung cancer were divided into two groups.control group(n=50) were treated with routine treatment, experiment group(n=50) on the base of the control group with 0.3 g cinobufacin,3 times per day oral.P53, PTEN, HIF-1α,tumor marker,survival rate and mortality were compared after the treatment.Results Compared with the control group,the serum levels of P53, HIF-1αexpression level was lower(P<0.05),PTEN expression level was higher (P<0.05),CEA,NSE,CYFRA21-1,CA125 were lower(P<0.05);the survival rate was higher, the mortality was lower(P<0.05). Conclusion Cinobufacin can regulate the advanced lung cancer patients serum P53, PTEN and HIF-1αlevels and reduce the tumor markers levels, improve the survival rate.It is of great importance for clinical treatment of advanced lung cancer.
